References

Al-Attas, R.A., M. Al-Khalifa, A.R. Al-Qurashi, M. Badawy and N. Al-Gualy, 2000. Evaluation of PCR, culture and serology for the diagnosis of acute human brucellosis. Ann. Saudi Med., 20: 224-228.
PubMed  |  

Andrew, H., J. Love, P.N. Leahy and A. Miller, 1973. Letter: Contracting brucellosis from S19 vaccine. Vet. Rec., 93: 380-380.
PubMed  |  

Bhattacharjee, A.K., L. van de Verg, M.J. Izadjoo, L. Yuan, T.L. Hadfield, W.D. Zollinger and D.L. Hoover, 2002. Protection of mice against brucellosis by intranasal immunization with Brucella melitensis lipopolysaccharide as a noncovalent complex with Neisseria meningitidis group B outer membrane protein. Infect. Immunity, 70: 3324-3329.
CrossRef  |  PubMed  |  Direct Link  |  

Bowden, R.A., S.M. Estein, M.S. Zygnnunt, G. Dubray and A. Cloeckaert, 2000. Identification of protective outer membrane antigens of Brucella ovis by passive immunization of mice with monoclonal antibodies. Microbes Infect., 2: 481-488.
CrossRef  |  Direct Link  |  

Buzgan, T., M.K. Karahocagil, H. Irmak, A.I. Baran, H. Karsen, O. Evirgen and H. Akdeniz, 2010. Clinical manifestations and complications in 1028 cases of brucellosis: A retrospective evaluation and review of the literature. Int. J. Infect. Dis., 14: e469-e478.
CrossRef  |  PubMed  |  

Cardoso, P.G., G.C. Macedo, V. Azevedo and S.C. Oliveira, 2006. Brucella sp. noncanonical LPS: Structure, biosynthesis and interaction with host immune system. Microb. Cell Factories, 5: 13-13.
CrossRef  |  PubMed  |  

Chimana, H.M., J.B. Muma, K.L. Samui, B.M. Hangombe and M. Munyeme et al., 2010. A comparative study of the seroprevalence of brucellosis in commercial and small-scale mixed dairy-beef cattle enterprises of Lusaka province and Chibombo district, Zambia. Trop. Anim. Health Prod., 42: 1541-1545.
CrossRef  |  PubMed  |  

Cloeckaert, A., N. Vizcaino, J.Y. Paquet, R.A. Bowden and P.H. Elzer, 2002. Major outer membrane proteins of Brucella sp.: Past, present and future. Vet. Microbiol., 90: 229-247.
CrossRef  |  PubMed  |  Direct Link  |  

Davis, D.S. and P.H. Elzer, 2002. Brucella vaccines in wildlife. Vet. Microbiol., 90: 533-544.
CrossRef  |  PubMed  |  

De Mot, R., I. Nagy, G. Schoofs and J. Vanderleyden, 1996. Identification of a Rhodococcus gene cluster encoding a homolog of the 17-kDa antigen of Brucella and a putative regulatory protein of the AsnC-Lrp family. Curr. Microbiol., 33: 26-30.
CrossRef  |  

Emslie, F.R. and J.R. Nel, 2002. An overview of the eradication of Brucella melitensis from KwaZulu-Natal. Onderstepoort J. Vet. Res., 69: 123-127.
PubMed  |  Direct Link  |  

Erasmus, J.A. and E.C. Bergh, 1985. Ovine brucellosis: Repeated vaccination with Rev 1 vaccine and the prevalence of the disease in the Winburg district. J. S. Afr. Vet. Assoc., 56: 205-208.
PubMed  |  

Franco, M.P., M. Mulder, R.H. Gilman and H.L. Smits, 2007. Human brucellosis. Lancent Infect. Dis., 7: 775-786.
CrossRef  |  PubMed  |  Direct Link  |  

Giorgio, A., G. de Stefano, L. Tarantino, G. Liorre, V. Scala and R. De Sena, 2003. Subphrenic abscess during the course of acute brucellosis: Diagnosis and treatment with percutaneous sonographically-guided drainage. Infez. Med., 11: 35-39.
PubMed  |  

Glynn, M.K. and T.V. Lynn, 2008. Brucellosis. J. Am. Vet. Med. Assoc., 233: 900-908.

Gonzalez, D., M.J. Grillo, M.J. De Miguel, A. Tara and V. Arce-Gorvel et al., 2008. Brucellosis vaccines: Assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and o-polysaccharide synthesis and export. PLoS One, 3: e2760-e2760.
CrossRef  |  PubMed  |  Direct Link  |  

Hemmen, F., V. Weynants, T. Scarcez, J.J. Letesson and E. Saman, 1995. Cloning and sequence analysis of a newly identified Brucella abortus gene and serological evaluation of the 17-kilodalton antigen that it encodes. Clin. Diagn. Lab. Immunol., 2: 263-267.
PubMed  |  

Pasquevich, K.A., S.M. Estein, C. Garcia-Samartino, A. Zwerdling and L.M. Coria et al., 2009. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4⁺ and CD8⁺ T cells as well as systemic and oral protection against Brucella abortus infection. Infect. Immunity, 77: 436-445.
CrossRef  |  PubMed  |  Direct Link  |  

Schurig, G.G., R.M. Roop, T. Bagchi, S. Boyle, D. Buhrman and N. Sriranganathan, 1991. Biological properties of RB51; A stable rough strain of Brucella abortus. Vet. Microbiol., 28: 171-188.
CrossRef  |  Direct Link  |  

Shumilov, K.V., O. Sklyarov and A. Klimanov, 2010. Designing vaccines against cattle brucellosis. Vaccine, 28: F31-F34.
CrossRef  |  Direct Link  |  

Skalsky, K., D. Yahav, J. Bishara, S. Pitlik, L. Leibovici and M. Paul, 2008. Treatment of human brucellosis systematic review and meta-analysis of randomised controlled trials. BMJ, 336: 701-704.
CrossRef  |  Direct Link  |  

Tibor, A., E. Saman, P. de Wergifosse, A. Cloeckaert, J.N. Limet and J.J. Letesson, 1996. Molecular characterization, occurrence and immunogenicity in infected sheep and cattle of two minor outer membrane proteins of Brucella abortus. Infect. Immun., 64: 100-107.
PubMed  |  

Tibor, A., V. Wansard, V. Bielartz, R.M. Delrue and I. Danese et al., 2002. Effect of omp10 or omp19 deletion on Brucella abortus outer membrane properties and virulence in mice. Infect. Immun., 70: 5540-5546.
CrossRef  |  PubMed  |  

Winter, A.J., G.E. Rowe, J.R. Duncan, M.J. Eis, J. Widom, B. Ganem and B. Morien, 1988. Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in mice. Infect. Immun., 56: 2808-2817.
PubMed  |